Rocket One Inc. Investments, Fair Value Disclosure
Rocket One Inc. (RKTO) had Investments, Fair Value Disclosure of $33.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:InvestmentsFairValueDisclosure · last filed 2023-11-13
- 2023-09-30: Investments, Fair Value Disclosure $33.00K.
- 2023-06-30: Investments, Fair Value Disclosure $33.00K.
- 2023-03-31: Investments, Fair Value Disclosure $33.00K.
- 2022-12-31: Investments, Fair Value Disclosure $33.00K.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $33.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $33.00K 10-Q · filed 2023-11-13 |
| 2023-03-31 | $33.00K 10-Q · filed 2023-08-11 |
| 2022-12-31 | $33.00K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $387.40K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $387.40K 10-Q · filed 2023-11-13 |
| 2022-03-31 | $410.00K 10-Q · filed 2023-08-11 |
| 2021-12-31 | $410.00K 10-Q · filed 2023-11-13 |
| 2020-12-31 | $410.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |